Iovance Biotherapeutics Inc FDA Approval Call Transcript
Good day and thank you for standing by. Welcome to AMTAGVI's FDA approval conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Sara Pellegrino, Senior Vice President, Investor Relations and Corporate Communications. Please go ahead.
Thank you, operator. Good afternoon, and thank you for joining this conference call and webcast to discuss the US FDA approval of AMTAGVI in advanced melanoma.
Dr. Fred Vogt, our Interim President and Chief Executive Officer, will provide a brief introduction and key highlights from the label. Jim Ziegler, EVP Commercial, will discuss next steps for commercial launch. And Fred will conclude the call with further details on value and access. Additional members of the senior leadership team are also on the call and available for the Q&A session.
Earlier, we issued
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
